138 related articles for article (PubMed ID: 35905218)
1. Expression of chemokine CXCL8/9/10/11/13 and its prognostic significance in head and neck cancer.
Zhao Z; Ma Y; Lv J; Maimaiti N; Zhang J; Aibibula M; Gong Z; Ling B
Medicine (Baltimore); 2022 Jul; 101(30):e29378. PubMed ID: 35905218
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma.
Li Y; Wu T; Gong S; Zhou H; Yu L; Liang M; Shi R; Wu Z; Zhang J; Li S
Front Oncol; 2020; 10():570736. PubMed ID: 33489879
[TBL] [Abstract][Full Text] [Related]
3. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of differentially methylated expressed genes and site-specific methylation as potential prognostic markers in head and neck cancer.
Bai G; Song J; Yuan Y; Chen Z; Tian Y; Yin X; Niu Y; Liu J
J Cell Physiol; 2019 Dec; 234(12):22687-22702. PubMed ID: 31131446
[TBL] [Abstract][Full Text] [Related]
5. Integrative Analysis Identified CD38 As a Key Node That Correlates Highly with Immunophenotype, Chemoradiotherapy Resistance, And Prognosis of Head and Neck Cancer.
He Z; Yue C; Chen X; Li X; Zhang L; Tan S; Yi X; Luo G; Zhou Y
J Cancer; 2023; 14(1):72-87. PubMed ID: 36605482
[TBL] [Abstract][Full Text] [Related]
6. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods.
Jin Y; Yang Y
Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688
[TBL] [Abstract][Full Text] [Related]
7. [Expression and clinical significance of HIST1H2BH in head and neck squamous cell carcinoma].
Wang SP; Ding ZX; Meng J; Li M; Li XD; Yuan Z
Shanghai Kou Qiang Yi Xue; 2021 Dec; 30(6):599-605. PubMed ID: 35587014
[TBL] [Abstract][Full Text] [Related]
8. Identifying potential prognostic biomarkers in head and neck cancer based on the analysis of microRNA expression profiles in TCGA database.
Wang X; Yin Z; Zhao Y; He M; Dong C; Zhong M
Mol Med Rep; 2020 Mar; 21(3):1647-1657. PubMed ID: 32016476
[TBL] [Abstract][Full Text] [Related]
9. Pseudogene Transcripts in Head and Neck Cancer: Literature Review and
Carron J; Della Coletta R; Lourenço GJ
Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440428
[TBL] [Abstract][Full Text] [Related]
10. Interferon Regulatory Factor Family Genes: At the Crossroads between Immunity and Head and Neck Squamous Carcinoma.
Liu S; Wang Z
Dis Markers; 2022; 2022():2561673. PubMed ID: 35664436
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor.
Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y
Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149
[TBL] [Abstract][Full Text] [Related]
12. Bioinformatics analysis of the transcriptional expression of minichromosome maintenance proteins as potential indicators of survival in patients with cervical cancer.
Wu B; Xi S
BMC Cancer; 2021 Aug; 21(1):928. PubMed ID: 34404366
[TBL] [Abstract][Full Text] [Related]
13. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis.
Ding Y; Li M; Tayier T; Chen L; Feng S
Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035
[TBL] [Abstract][Full Text] [Related]
14. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
[TBL] [Abstract][Full Text] [Related]
15. Unraveling most abundant mutational signatures in head and neck cancer.
Plath M; Gass J; Hlevnjak M; Li Q; Feng B; Hostench XP; Bieg M; Schroeder L; Holzinger D; Zapatka M; Freier K; Weichert W; Hess J; Zaoui K
Int J Cancer; 2021 Jan; 148(1):115-127. PubMed ID: 32930393
[TBL] [Abstract][Full Text] [Related]
16. Combined expression and prognostic significance of PPFIA1 and ALG3 in head and neck squamous cell carcinoma.
Zhou H; Cao T; Li WP; Wu G
Mol Biol Rep; 2019 Jun; 46(3):2693-2701. PubMed ID: 30805892
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of BASP1 Indicates a Poor Prognosis in Head and Neck Squamous Cell Carcinoma.
Jaikumarr Ram A; Girija As S; Jayaseelan VP; Arumugam P
Asian Pac J Cancer Prev; 2020 Nov; 21(11):3435-3439. PubMed ID: 33247706
[TBL] [Abstract][Full Text] [Related]
18. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study.
Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M
Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck.
Zhu Y; Zheng S; Zhai X; Wang C; Liu A; Ju J; Peng X; Chen L; Zhang Y; Ren N; Xie Y; Fan J; Zhao K; Liu M
J Immunol Res; 2022; 2022():5501476. PubMed ID: 35478939
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of DFNA5 in head and neck squamous cell carcinoma revealed by systematic expression analysis.
Liu Z; Liu H; Dong Q; Li H; Zhang B; Liu Y; Zhong L; Tang H
BMC Cancer; 2021 Aug; 21(1):951. PubMed ID: 34433433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
